专利号:US-5945414-A 优先权日:1996-12-03 标 题:Process for the preparation of new intermediates useful in the synthesis of cephalosporins 发明人:SOGLI LORIS; TERRASSAN DANIELE; BERNASCONI ERMANNO; SALTO FRANCISCO 权利人:ANTIBIOTICOS SPA 摘要:Cefazolin, cefazedone, cefoperazone, cefamandole, cefatrizine or ceftriaxone is prepared by reacting glutaryl 7-ACA of the formula: with a compound of formula (II): R-SH(II) wherein R is 5-methyl-1,3,4-thiadiazol-2-yl, 1H-1,2,3-triazol-4-yl, 1-methyl-tetrazol-5-yl or 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-1,2,4-triazin-3-yl group, and R1 and R2 are both hydrogen and the other is an acyl group, in an aqueous solution in an amount of 3-5 mols per mol of glutaryl 7-ACA to about 90 DEG C. and for a time from about 2 to about 10 hours; optionally recovering the excess of the compound of formula (II), thereby preparing a compound of formula (III) in an aqueous solution: wherein R is as above defined and optionally deacylating said compound of formula (III); and converting the resulting compound of formula (I) wherein R, R1 and R2 are as defined above in the presence of a non-chlorinated solvent into one of said cephalosporins.
专利号:US-8017776-B2 优先权日:2003-07-15 标题 :Methods for synthesis of acyloxyalkyl compounds 发明人:BHAT LAXMINARAYAN; GALLOP MARK A 权利人:XENOPORT INC 摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.
专利号:US-8143437-B2 优先权日:2002-02-19 标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof 发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X 权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC 摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.
专利号:US-5387679-A 优先权日:1991-07-15 标题 :Process for the preparation of cephalosporins intermediates 发明人:SOGLI LORIS; TERRASSAN DANIELE; RIBALDONE GIUSEPPE 权利人:ANTIBIOTICOS SPA 摘要:PCT No. PCT/EP92/01595 Sec. 371 Date Mar. 15, 1993 Sec. 102(e) Date Mar. 15, 1993 PCT Filed Jul. 14, 1992 PCT Pub. No. WO93/02085 PCT Pub. Date Feb. 4, 1993.The present invention relates to a process for preparing a compound of formula (I) ntains at least one nitrogen atom with or without oxygen or sulphur and R1 and R2 are both hydrogen atoms or one of them is an hydrogen atom and the other is an acyl group; the process comprising reacting a compound of formula (II) (II) wherein R1 and R2 are each as defined above, and wherein, if necessary, any reactive group is protected by a suitable protective group, or a salt thereof, with a compound of formula (III) R-SH(III) wherein R is as defined above, or a salt thereof, in the presence of an acid and of a compound of formula (IV) (IV) wherein each of R3 and R4 is a C1-C4 alkyl group or R3 and R4 taken together are a C2 or C3 alkylene chain and, if necessary, removing the protective groups possibly present. The compounds of formula (I) are useful intermediates in the synthesis of Cefazolin and Cefazedone.
专利号:WO-0032619-A1 优先权日:1998-11-30 标题:Methods and compositions for identification of inhibitors of ribosome assembly 发明人:DAMMEL CAROL S; WATSON JULIE C 权利人:RIBOGENE INC 摘要:The invention provides a means for identifying novel antibiotics by screening for compounds that inhibit bacterial ribosome assembly and ribosomal protein synthesis, which comprises the screening of test compounds to identify those that inhibit the activity of a bacterial ribosomal protein. The in vitro and in vivo assays detect (a) increased translation of a reporter mRNA that is normally repressed in the presence of a ribosomal protein, (b) increased growth in cells that over-express ribosomal protein, and (c) decreased binding of the ribosomal protein to its target RNA. The invention encompasses the (a) methods of screening and testing compounds by the above methods, (b) compounds that are identified in the assay which inhibit ribosome assembly and protein synthesis and (c) methods for treatment using said compounds.
专利号:US-2025002508-A1 优先权日:2020-05-05 标题 :Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof 发明人:HECKER SCOTT J; BOYER SERGE HENRI; BIO MATTHEW M; FANG YUANQING; GONZALES DE CASTRO ANGELA; LEFORT LAURENT; ZHU ZUOLIN; LINDER THOMAS 权利人:QPEX BIOPHARMA INC 摘要:Disclosed herein are antimicrobial compounds, polymorphic forms, compositions, pharmaceutical compositions, the method of use and preparation thereof. Some embodiments relate to boronic acid derivatives and their use as therapeutic agents, for example, β-lactamase inhibitors (BLIs).
1: Wu D, Qian ZY, Guo T, Tang W, Xiang Y, Zheng H. Determination of cefazedone in human plasma by high performance liquid chromatography-tandem mass spectrometry: Application to a pharmacokinetic study on Chinese volunteers. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Oct 15;878(28):2911-5. doi: 10.1016/j.jchromb.2010.08.008. Epub 2010 Aug 17. 128(9):1160-4. doi: 10.4103/0366-6999.156086. 3: Adam D, Hofstetter AG, Reichart B, Schneider C, Wolff H, Koch E. Zur Diffusion von Cefazedon in das Herzmuskel-, Prostata- und Hautgewebe sowie in die Gallenflüssigkeit [The diffusion of cefazedone into heart muscle, prostatic and skin tissue and into bile]. Arzneimittelforschung. 1979;29(12):1901-6. German. 90(1):135-42. doi: 10.1016/0041-008x(87)90314-0. 973C:97-103. doi: 10.1016/j.jchromb.2014.10.018. Epub 2014 Oct 23. 29(2a):449-52. 29(2a):412-4. 29(2a):437-43. 29(2a):381-4. 122(12):431-4. German. 6(2):288-91. doi: 10.1093/jac/6.2.288. 97(5):214-8. German. 29(2a):456-60. 29(2a):461-2. 29(2a):369-78. 29(2a):400-3. 29(2a):435-6. 29(2a):384-7. 29(2a):453-6. 28(2):71-8. doi: 10.1002/ajh.2830280202. Erratum in: Am J Hematol 1988 Dec;29(4):241.
合成参考文献
摘要:Hitzenberger G, Jaschek I. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)]. Wien Med Wochenschr. 1980 Feb 15;130(3):135–42.